AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05663177 — intervention group
Intervention type: DRUG
Intervention: Almonertinib and metronomic oral vinorelbine
Description: Ametinib 110mg once a day; Oral Vinorelbine 40mg three times a week for three weeks and Q28d for one course.
Study NCT05483712 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Brass Mesh Bolus
Description: During a standard-of-care 15 fraction radiotherapy treatment, a brass mesh bolus will be used for a single fraction. Small in-vivo dosimeters will be used for three treatment fractions to measure and compare skin doses for quantification purposes.
Study NCT05017987 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ATB-101, ATB-1011, ATB-1012
Description: 1. Test drug~   - Code name: ATB-101~2. Control drug1~   * Code name: ATB-1011~  * Active ingredient: Olmesartan~3. Control drug2~   * Code name: ATB-1012~  * Active ingredient: Dapagliflozin
Study NCT05283122 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mostafa Maged Technique
Description: pfannestiel incision . dissection of the bladder downwards , and Ligation of the uterine arteries on both sides then , we turn over the upper part of the lower uterine segment onto the lower part of the lower uterine segment from the inside of uterine cavity .We do this turnover (flipping ) by our hands and holding the imaginary line by two Allis forceps and by making three knots by three needles in the lower edge of the uterine incision and we enter the needles of simultaneously into the lower segment through the uterine cavity , at the same level of , the inside wall of lower uterine segment to drag the upper (half) part of the lower uterine segment on the lower part of lower uterine segment ( sandwich - like ) Third , we stitch the both sides of the flipped lower uterine segment , then we do plication of the anterior lower uterine segments to strengthen the wall of the flipped lower uterine segment and place a drain in the doglus pouch
Study NCT04974385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Description: Validate the analgesic efficacy of admixed LB + bupivacaine compared with plain bupivacaine when injected for ISNB for total shoulder arthroplasty.
Study NCT04974385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: Active comparator as standard of care.
Study NCT04974385 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: Active comparator as standard of care.
Study NCT06294223 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exercise follow up with near-infrared spectroscopy
Description: Exercises will be followed by near-infrared spectroscopy. Fatigue protocol will be applied.
Study NCT04320251 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cochlear implant revision surgery
Description: Observation during routine cochlear implant revision surgery
Study NCT05189444 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan
Description: 20mg bid
Study NCT05189444 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: 0.75g tid
Study NCT05189444 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esomeprazole
Description: 20mg bid
Study NCT05189444 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin
Description: 1.0g bid
Study NCT05189444 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clarithromycin
Description: 0.5g bid
Study NCT05189444 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bismuth potassium citrate
Description: 0.22g bid
Study NCT05189444 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bismuth potassium citrate
Description: 0.22g bid
Study NCT06221761 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: not using antibiotic
Description: no antibiotic application
Study NCT06221761 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: using antibiotic
Description: antibiotic application
Study NCT04981639 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: IVPCA
Description: Intravenous patient controlled analgesia will be performed.
Study NCT04981639 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TAP
Description: Transversus abdominis plane block will be performed.
Study NCT04981639 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: IMS
Description: Intramuscular electrical stimulation will be performed.
Study NCT05864430 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Face-to-face Training Group
Description: The training will take approximately 3 hours. The training will be done interactively, allowing students to talk to each other and ask questions, and will end with 10 minutes of time for students' questions.
Study NCT05864430 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DataMatrix supported Face-to-face training group
Description: Students will follow the lesson with the QR code given simultaneously with the training given during the education process. The training will be held in such a way that the students will be given the opportunity to ask questions and will end with 10 minutes of time to be given to the questions of the students.
Study NCT05864430 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online training group
Description: The training will take approximately 3 hours. The training will be done interactively, allowing students to talk to each other and ask questions, and will end with 10 minutes of time for students' questions.
Study NCT05419284 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GAPP+Care
Description: standard physiotherapy 45 minutes per day, 5 day a week (GAPP)~+ 3 extra exercise sessions led by a caregiver (+Care)
Study NCT05419284 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: +Care
Description: 3 extra exercise moments led by a caregiver: one physiotherapist-caregiver-patient exercise session: the physiotherapist will educate and train the caregiver on the exercises and hands-on skills.~Two caregiver-patient exercise sessions
Study NCT05419284 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Observation of GAPP+Care
Description: Healthcare workers in the geriatric rehabilitation ward will be interviewed on their opinions on GAPP+Care
Study NCT06593639 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prehabilitation before surgery
Description: Prehabilitation multimodal program will start about 4 weeks before the surgery and will be continued until 2 weeks after the surgical intervention. Multimodal program comprises physical exercise, nutritional intervention, and psychological support provided before and during curative treatment for HNC patients.
Study NCT06593639 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prehabilitation before and during CRT
Description: Prehabilitation multimodal program will start about 4 weeks CRT and will be continued in parallel until 2 weeks after the end. Multimodal program comprises physical exercise, nutritional intervention, and psychological support provided before and during curative treatment for HNC patients.
Study NCT06598878 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: AR gait training
Description: Participants will walk on a pathway projected in augmented reality (AR), following the instructions provided on the pathway Each session will last for 60 minutes, conducted three times per week, over a period of six weeks.
Study NCT06633029 — intervention group
Intervention type: DEVICE
Intervention: Prismaflex HF20
Description: CRRT fluid management and reduction of uremic toxins.
Study NCT06633029 — intervention group
Intervention type: DEVICE
Intervention: Prismaflex M60
Description: CRRT fluid management and reduction of uremic toxins.
Study NCT06632392 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simulation training
Description: Theory and simulation training
Study NCT06632392 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Theory training
Description: Theory training
Study NCT06632392 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Theory training
Description: Theory training
Study NCT06633068 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Adding perineural Nalbuphine to Bupivacaine in superficial cervical nerve block
Description: Adding nalbuphine as an adjuvant to bupivacaine in superficial cervical plexus block during thyroid surgeries
Study NCT06633068 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adding perineural Nalbuphine to Bupivacaine in superficial cervical nerve block
Description: Adding nalbuphine as an adjuvant to bupivacaine in superficial cervical plexus block during thyroid surgeries
Study NCT06633679 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Se Cuida Intervention
Description: The intervention consist in an internet based cognitive behavioural therapy program delivered through a online platform. Intervention consist of 8 weeks with 8 weekly modules assigned to the participants. The program has been translated and adapted to the Brazilian and is based on CBT techniques focused on managing psychological symptoms of anxiety and depression in young people. Out of a total 14 modules adaptaded, 8 will be delivered in the treatment: 5 will be available to all participants and 3 will be tailored according to the initial assessment and interviews. The intervention is self-guided with support on demand, meaning that when participants need support, they could chat directly through the platform text message channel with a psychoteraphist responsible for them. Also, once a week each participants receive feedbacks regarding their work on the program\&#39;s exercises.
Study NCT06633172 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: laparoscopic ventral mesh rectopexy
Description: performing ventral mesh rectopexy via laparoscopic surgery to correct the anterior rectocele.
Study NCT06633172 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Trans vaginal repair
Description: performing repair of the rectocele through the recto vaginal septum repair.
Study NCT06632899 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: combined physical and cognitive training and 1 hour of risk factor prevention and healthy lifestyle development
Description: Dosage: a 2-hour session once a week for 12 weeks. Each multidomain intervention session includes 1 hour of combined physical (balance, strength and aerobic exercises) and cognitive (attention, memory, calculation, visual-spatial ability, processing speed and executive function) training and 1 hour of risk factor prevention (nutrition, chronic disease management, oral health, fall prevention and transportation safety, psychosocial factors and sleep) and healthy lifestyle development (Discussion and sharing on topics such as self-health management, goal setting, and the health journal.)
Study NCT06251492 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy
Description: 8 Gray x 3 for 2 cycles
Study NCT06251492 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: Adebrelimab 20mg/kg IV Q3W for 2 cycles, then Adebrelimab 20mg/kg IV alone Q3W until progression
Study NCT06241560 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1015550
Description: BI 1015550
Study NCT06241560 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Description: Pirfenidone
Study NCT06286800 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) with OT
Description: Weak direct current (0.5-2 mA) will be delivered for up to 20 minutes through surface electrodes which will be positioned using the ptDCS montage. The current will be increased and decreased ramp-like at the beginning and end of the 20-minute stimulation to lessen the itchy/numb skin sensation and decrease the likelihood of an innocuous phosphene-like visual phenomenon. The stimulation will be delivered during the first 20 minutes of occupational therapy targeted to the more affected upper extremity.
Study NCT06286800 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham tDCS with OT
Description: Same procedure and montage as with the active stimulation but the current will be increased then decreased ramp-like and switched off after 20 seconds instead of the 20 minutes to elicit the same cutaneous sensation as the other stimulation conditions. \[69\] This short length of stimulation is documented to elicit sensations comparable to those of real stimulation. With this procedure, subjects were unable to differentiate between tDCS and sham stimulation in our and other previous studies.
Study NCT06285253 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: miroliverELAP treatment
Description: Subject's blood will be perfused through a bioengineered liver graft via an extracorporeal blood circuit.
Study NCT05104866 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dato-DXd
Description: Experimental drug. Provided in 100mg vials. IV infusion.
Study NCT05104866 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine
Description: Tablet. Oral route of administration. Active comparator
Study NCT05104866 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Description: IV Infusion. Active comparator
Study NCT05104866 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Eribulin
Description: IV Infusion. Active comparator
Study NCT05104866 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vinorelbine
Description: IV Infusion. Active comparator
Study NCT04958317 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Early exercise
Description: Participants will exercise for 30 minutes prior to an evening meal.
Study NCT04958317 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Late exercise
Description: Participants will exercise for 30 minutes after an evening meal.
Study NCT06499441 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial induction in gastrocnemius
Description: A 3-pass shallow leg gliding technique was applied first, followed by 5 minutes of the deep myofascial calf induction technique described by Pilat.
Study NCT06499441 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Preassure release
Description: Also called ischaemic pressure. Three cycles of pressure are applied to the trigger point of the gastrocnemius muscle until the pain disappears on pressure.
Study NCT05727527 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local Anesthesia 1
Description: Local anesthesia injection after applying a candy flavor
Study NCT05296889 — intervention group
Intervention type: DEVICE
Intervention: posterior stabilization for the cervical spine
Description: The Ennovate® Cervical Spinal System is a posterior stabilization for the cervical and upper-thoracic spine. The implants are used for the posterior monosegmental and multisegmental stabilization of the occipitocervical junction and of the cervical and upper thoracic spine.
Study NCT06324786 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IBMT
Description: IBMT is an effortless mindfulness technique
Study NCT06488092 — intervention group
Intervention type: OTHER
Intervention: Cesarean Risk Calculator
Description: The cesarean risk calculator will be incorporated into routine care at the site
Study NCT06194942 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: chiropractic manipulation
Description: Chiropractic manipulation is a manual therapy technique commonly used by chiropractors. It involves the application of controlled, sudden force to a specific joint, often with the goal of improving joint function, reducing pain, and promoting overall musculoskeletal health.In the context of thoracic chiropractic manipulation, the chiropractor focuses on the vertebrae and joints in the thoracic spine.
Study NCT06194942 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: sham manipulation
Description: Sham manipulation refers to a simulated or placebo form of a manual therapy intervention, often used in research studies, especially in clinical trials involving chiropractic or physical therapy. the term sham manipulation likely implies a procedure that mimics the physical aspects of a real chiropractic manipulation but does not involve the actual therapeutic forces or movements.~The chiropractic treatment group received thoracic chiropractic manipulations (HVLA) twice a week for a total of six sessions over three weeks, while the control group received sham manipulations.
Study NCT04676087 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Extracorporeal Photopheresis
Description: Undergo ECP
Study NCT04676087 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mogamulizumab
Description: Given IV
Study NCT04676087 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT05568680 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
Description: Autologous T cells Transduced with Mesothelin KIR-CAR
Study NCT05727527 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local Anesthesia 2
Description: Local anesthesia injection after applying sterile water
Study NCT06324786 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: NF
Description: NF is a mental training technique.
Study NCT06324786 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: NF
Description: NF is a mental training technique.
Study NCT05958888 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text only sodium label
Description: Warning: High in sodium. is shown in a black square label on the can of soup.
Study NCT05958888 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Icon sodium label
Description: Warning: High in sodium. is shown beneath a yellow triangle icon with an exclamation mark all in a black square label on the can of soup.
Study NCT05958888 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pictorial sodium label
Description: Warning: High in sodium. is shown beneath an image of a spilled salt shaker, all in a black square label on the can of soup.
Study NCT05958888 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Barcode label
Description: Barcode is shown in white square label on the can of soup
Study NCT06112496 — intervention group
Intervention type: DEVICE
Intervention: EMG
Description: Neuro-EMG-Micro, Neurosoft, Ivanovo, Russia, will be used for the assessment of muscle activity for muscles.
Study NCT04857840 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Firibastat (QGC001) Period 1
Description: 1000 mg (2 x 500 mg) tablets QD per Os
Study NCT06230887 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Building Spiritual Strength
Description: Spiritually Integrated group intervention for moral injury
Study NCT06230887 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Present Centered Group Therapy
Description: Active control, manualized evidence-based coping skills intervention for PTSD
Study NCT04857840 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Firibastat (QGC001) Period 1
Description: 1000 mg (2 x 500 mg) tablets QD per Os
Study NCT05022693 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIO89-100
Description: Subcutaneous Injections
Study NCT05415865 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Alkalinized Lidocaine
Description: 20 ml of Lidocaine Hydrochloride and 10 ml of Sodium hydrogen carbonate will be pulled up and mixed in a syringe on site, and 30 ml mixed solution in total will afterwards be installed in the bladder with a catheter.
Study NCT05415865 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Sodium Chloride 0.9% Inj
Description: 20 ml of Sodium Chloride 9 g/L and 10 ml of Sodium Chloride 9 g/L will be pulled up and mixed in a syringe on site, and 30 ml solution in total will afterwards be installed in the bladder with a catheter.
Study NCT06411106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMIQUIMOD cream 50mg/g
Description: 5 mg imiquimod (100mg Aldara®) per treatment site with a 12mm Finn chamber
Study NCT05940857 — intervention group
Intervention type: DEVICE
Intervention: OCS Liver
Description: The TransMedics® Organ Care System (OCS) Liver is an FDA approved portable extracorporeal liver perfusion and monitoring system.
Study NCT06096090 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Interleukin-2
Description: Low dose Interleukin-2 (Aldesleukin) administration to expand Regulatory T cells
Study NCT06096090 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administration
Study NCT06446375 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: FIFA 11+ KIDS Training Protocol consists of seven different exercises: three for unilateral, dynamic stability of the lower limbs (hopping, jumping and landing); three for whole body and trunk strength/stability; and one exercise on falling technique.
Study NCT06446375 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Regular daily activity
Description: Regular physical activity